CD14 (C-159T) polymorphism is associated with increased susceptibility to SLE, and plasma levels of soluble CD14 is a novel biomarker of disease activity: A hospital-based case-control study
| Image |  |
|---|---|
| Description | scientific article published on 11 November 2020 |
| Author/s |
author: Aditya K Panda |
| Publication date | November 11, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |